-
Loading metrics
Open Access
Peer-reviewed
Research Article
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
-
Katherine E. Zarn ,
Contributed equally to this work with: Katherine E. Zarn, Sierra A. Jaramillo
Roles Data curation, Formal analysis, Investigation, Visualization, Writing – review & editing
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Sierra A. Jaramillo ,
Contributed equally to this work with: Katherine E. Zarn, Sierra A. Jaramillo
Roles Formal analysis, Investigation
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Anthony R. Zapata,
Roles Investigation
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Nathan E. Stone,
Roles Methodology, Writing – review & editing
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Ashley N. Jones,
Roles Investigation
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Haley E. Nunnally,
Roles Investigation
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Erik W. Settles,
Roles Conceptualization, Supervision, Writing – review & editing
Affiliations Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Ken Ng,
Roles Visualization
Affiliation Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Paul S. Keim,
Roles Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing
Affiliations Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯ -
Steen Knudsen,
Roles Conceptualization, Funding acquisition, Project administration
Affiliation Allarity Therapeutics Europe, Hørsholm, Denmark
⨯ - Patricia M. Nuijten,
-
Aloys S. L. Tijsma,
Roles Investigation, Project administration, Writing – review & editing
Affiliation Viroclinics-DDL, Rotterdam, The Netherlands
⨯ -
Christopher T. French
Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: ctfrench@nau.edu
Affiliations Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America, Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, United States of America, COVID-19 Testing Service Center, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America
⨯
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
- Katherine E. Zarn,
- Sierra A. Jaramillo,
- Anthony R. Zapata,
- Nathan E. Stone,
- Ashley N. Jones,
- Haley E. Nunnally,
- Erik W. Settles,
- Ken Ng,
- Paul S. Keim,
- Steen Knudsen
- Published: September 14, 2022
- https://doi.org/10.1371/journal.pone.0272916